{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:40Z","timestamp":1786118740367,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/cmr.0b013e3280a608a4","type":"journal-article","created":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T04:04:13Z","timestamp":1178769853000},"page":"201-203","source":"Crossref","is-referenced-by-count":1,"title":["Association of hereditary haemorrhagic telangiectasia (Rendu\u2013Osler\u2013Weber syndrome) and malignant melanoma in two patients"],"prefix":"10.1097","volume":"17","author":[{"given":"Nicolas","family":"Kluger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rivi\u00e9re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Coupier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210309","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu\u2013Osler\u2013Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"R2-9-20210309","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/humu.9421","article-title":"Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients","volume":"27","author":"Lesca","year":"2006","journal-title":"Hum Mutat"},{"key":"R3-9-20210309","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/pmj.79.927.18","article-title":"Hereditary haemorrhagic telangiectasia (Osler\u2013Weber\u2013Rendu syndrome): a view from the 21st century","volume":"79","author":"Begbie","year":"2003","journal-title":"Postgrad Med J"},{"key":"R4-9-20210309","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00384-004-0607-3","article-title":"Does any lower gastrointestinal bleeding in patients suffering from hereditary hemorrhagic telangiectasia (Osler\u2013Weber\u2013Rendu) necessitate a full colonic visualization?","volume":"19","author":"Elinav","year":"2004","journal-title":"Int J Colorectal Dis"},{"key":"R5-9-20210309","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","article-title":"A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)","volume":"363","author":"Gallione","year":"2004","journal-title":"Lancet"},{"key":"R6-9-20210309","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0151-9638(06)70846-8","article-title":"Genetic and epidemiological aspects of melanoma","volume":"133","author":"Bataille","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"R7-9-20210309","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/humu.20342","article-title":"Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype","volume":"27","author":"Bossler","year":"2006","journal-title":"Hum Mutat"},{"key":"R8-9-20210309","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum Mol Genet"},{"key":"R9-9-20210309","first-page":"1154","article-title":"Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development","volume":"61","author":"Pollock","year":"2001","journal-title":"Cancer Res"},{"key":"R10-9-20210309","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.0303-6987.2005.00356.x","article-title":"Transforming growth factor-beta and malignant melanoma: molecular mechanisms","volume":"32","author":"Hussein","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R11-9-20210309","first-page":"2701","article-title":"Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma","volume":"18","author":"Bodey","year":"1998","journal-title":"Anticancer Res"},{"key":"R12-9-20210309","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/bjc.1996.593","article-title":"Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma","volume":"74","author":"Altomonte","year":"1996","journal-title":"Br J Cancer"},{"key":"R13-9-20210309","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","article-title":"Role of transforming growth factor beta in human disease","volume":"342","author":"Blobe","year":"2000","journal-title":"N Engl J Med"},{"key":"R14-9-20210309","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ijc.21077","article-title":"Association of hereditary hemorrhagic telangiectasia and hereditary nonpolyposis colorectal cancer in the same kindred","volume":"116","author":"Goldschmidt","year":"2005","journal-title":"Int J Cancer"},{"key":"R15-9-20210309","first-page":"1193","article-title":"Differential expression and cytoplasm\/membrane distribution of endoglin (CD105) in human tumour cell lines: implications in the modulation of cellproliferation","volume":"26","author":"Postiglione","year":"2005","journal-title":"Int J Oncol"},{"key":"R16-9-20210309","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/1568009033481741","article-title":"Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies","volume":"3","author":"Fonsatti","year":"2003","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CMR.0b013e3280a608a4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:36:14Z","timestamp":1786034174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008390-200706000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e3280a608a4","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}